Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial.
Lancet Infect Dis
; 21(8): 1151-1160, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33798487
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Strongyloidiasis
/
Strongyloides stercoralis
/
Macrolides
/
Anthelmintics
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2021
Document type:
Article
Affiliation country:
Suiza
Country of publication:
Estados Unidos